Algo version: 0.98b
Lyka Labs Limited is listed at the NSE Exchange
Lyka Labs Limited [LYKALABS.NS]
NSE Sector: Healthcare Industry:Biotechnology

Is Lyka Labs Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Lyka Labs Limited pays dividends. Last time was Tuesday 1st of October 1996 where the investors holding the stock on Monday 12th of August 1996 were paid INR2.5 per share. Over the last 2 times between 1995 and 1996, Lyka Labs Limited has paid INR5 with an average of INR2.5 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Lyka Labs Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR17.10, you would have made a profit of INR147.51 per share or 862.63%

Yes, the average daily trading liquidity for Lyka Labs Limited is INR377 741 thousand. You should therefore be able to get in and out of your positions relatively fast.

Lyka Labs Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.34, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Lyka Labs Limited to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.